A carregar...
Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatments for major depressive disorders (MDD). It has been reported, however, that 30–40% of patients with MDD who received SSRIs failed to respond to treatment. Use of lithium (Li) to augment SSRIs seems to be t...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4107705/ https://ncbi.nlm.nih.gov/pubmed/25057345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125313514767 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|